Novopyxis Competitors and Similar CompaniesClear all

Novopyxis's competitors and similar companies include Aquavit Pharmaceuticals, BL&H, Dong-A ST and ASKA Pharmaceutical.

	Novopyxis Novopyxis is a biotechnology company using mathematics and machine learning to engineer medical technology.	Aquavit Pharmaceuticals Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing, and commercializing pharmaceuticals, medical devices, and health technologies.	BL&H BL&H is a company developing and supplying drugs and medical devices.	Dong-A ST Dong-A ST is a healthcare company that specializes in the development of ethical drugs and medical devices.	ASKA Pharmaceutical ASKA Pharmaceutical (あすか製薬株式会社) is a company that develops, manufactures, and sells pharmaceutical products.
Founding Date	Founding Date 2013	Founding Date 2010	Founding Date 1999	Founding Date 1932	Founding Date 1920
Type	Type Private	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development medical devices medtech	Tags Healthcare biotech drug development medical devices medtech	Tags Healthcare biotech drug development medical devices medtech veterinary	Tags Healthcare biotech drug development medical devices medtech pharma	Tags Healthcare drug development pharma veterinary
Locations	Locations HQ	Locations New York, US HQ Do, KR	Locations HQ	Locations HQ	Locations Tokyo, JP HQ Chiba, JP Fujisawa, JP Fukuoka, JP Hiroshima, JP Iwaki, JP Kanazawa, JP see more
Employees	Employees 4	Employees 137% decrease	Employees N/A	Employees 1,533	Employees 635
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₩808.8b (FY, 2025)	Revenue (est.) ¥52.5b (FY, 2020)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₩456.1b (FY, 2025)	Cost of goods ¥24.9b (FY, 2020)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ₩356.5b (FY, 2025)	Gross profit ¥27.7b (FY, 2020)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income (₩37.6b) (FY, 2025)	Net income ¥649m (FY, 2020)

For sources of this data, please see the company profile

View Company Profiles

Aquavit Pharmaceuticals

New York, US

Employees

13↓ 7% decrease

Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing, and commercializing pharmaceuticals, medical devices, and health technologies.

View company

BL&H

BL&H is a company developing and supplying drugs and medical devices.

View company

Dong-A ST

Employees

1,533

Dong-A ST is a healthcare company that specializes in the development of ethical drugs and medical devices.

View company

ASKA Pharmaceutical

Tokyo, JP

ASKA Pharmaceutical (あすか製薬株式会社) is a company that develops, manufactures, and sells pharmaceutical products.